Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Gynecologic 1

Conditions

Solid Tumors 1Solid Tumor, Adult 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 1034Carboplatin 973Paclitaxel 942Gemcitabine 799Cisplatin 759Docetaxel 699Bevacizumab 637Nivolumab 520Pemetrexed 509Cyclophosphamide 476Capecitabine 475Fluorouracil 425Dexamethasone 410Rituximab 392Oxaliplatin 352Injections 349Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 252Ipilimumab 244Doxorubicin 242Lenalidomide 231Fulvestrant 226fludarabine 221durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × PankoMab-GEX × Clear all
NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed
50 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT01222624 2021-05-20

PankoMab-GEXâ„¢: Phase 1 Dose Escalation Study

Glycotope GmbH

Phase 1 Completed
74 enrolled
Other solid neoplasm

Solid Tumors

NCT01899599 2020-10-22

PankoMab-GEXâ„¢ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

Glycotope GmbH

Phase 2 Completed
216 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡